Lantern Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 05-12-2024
- Revenue 52.40%
(FY 2021)
- Profit 91.00%
(FY 2021)
- Ebitda 114.21%
(FY 2021)
- Net Worth 162.06%
(FY 2021)
- Total Assets 18.06%
(FY 2021)
About Lantern Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Tanay Tulsaney and Vaibhav Sharma serve as directors at the Company.
- CIN/LLPIN
U85200DL2018PTC337199
- Company No.
337199
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lantern Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tanay Tulsaney  | Director | 03-Aug-2018 | Current |
| Vaibhav Sharma | Director | 03-Aug-2018 | Current |
Financial Performance of Lantern Pharmaceuticals.
Lantern Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 52.4% increase. The company also saw a substantial improvement in profitability, with a 91% increase in profit. The company's net worth Soared by an impressive increase of 162.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lantern Pharmaceuticals?
In 2021, Lantern Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lantern Digital Services Private LimitedActive 9 years 8 monthsTanay Tulsaney and Vaibhav Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Feb 2024 | ₹1.00 Cr | Open |
How Many Employees Work at Lantern Pharmaceuticals?
Unlock and access historical data on people associated with Lantern Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lantern Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lantern Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
